Understanding the relationship between cuproptosis and the development of hepatocellular carcinoma: implications for targeted therapies

被引:0
作者
Zhu, Haixia [1 ,2 ]
Zhao, Yamin [3 ]
Wang, Yaxuan [1 ,2 ]
Wei, Guohua [1 ,2 ]
Liu, Jibin [1 ,2 ]
机构
[1] Nantong Univ, Affiliated Tumor Hosp, Inst Oncol, Nantong, Peoples R China
[2] Nantong Tumor Hosp, Nantong, Peoples R China
[3] Second Peoples Hosp Nantong, Internal Med, Nantong, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2025年 / 16卷
关键词
hepatocellular carcinoma; cuproptosis; prognosis; treatment resistance; immune microenvironment; SENSITIVITY;
D O I
10.3389/fimmu.2025.1557223
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatocellular carcinoma (HCC) presents a significant global health challenge, particularly in developing countries where its incidence is markedly elevated. Despite advancements in treatment modalities, the high malignancy, metastatic potential, and drug resistance associated with HCC contribute to poor clinical outcomes, underscoring the necessity for a more profound understanding of its pathogenesis. This review meticulously examines the role of copper apoptosis, a novel form of programmed cell death linked to dysregulated copper metabolism, in the development and progression of HCC. By conducting a comprehensive review of recent literature and experimental studies, we elucidate the molecular mechanisms through which excess copper induces oxidative stress, pyroptosis, and ferroptosis, thereby influencing tumorigenesis and progression. This review offers valuable insights into the intricate relationship between copper metabolism and HCC, positioning copper apoptosis as a potential therapeutic target to enhance treatment strategies and improve patient outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Targeted Therapies in Hepatocellular Carcinoma
    Bronte, F.
    Bronte, G.
    Cusenza, S.
    Fiorentino, E.
    Rolfo, C.
    Cicero, G.
    Bronte, E.
    Di Marco, V.
    Firenze, A.
    Angarano, G.
    Fontana, T.
    Russo, A.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (08) : 966 - 974
  • [2] Targeted systemic therapies for hepatocellular carcinoma:Clinical perspectives,challenges and implications
    Catherine Frenette
    Robert Gish
    World Journal of Gastroenterology, 2012, (06) : 498 - 506
  • [3] Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications
    Frenette, Catherine
    Gish, Robert
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (06) : 498 - 506
  • [4] Establishment and validation of a cuproptosis-related lncRNA signature that predicts prognosis and potential targeted therapy in hepatocellular carcinoma
    Guo, Ding-Fan
    Fan, Lin-Wei
    Zeng, Hai-Hui
    Huang, Cai-Bin
    Wu, Xin-Huan
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (02) : 739 - 764
  • [5] Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
    Alqahtani, Ali
    Khan, Zubair
    Alloghbi, Abdurahman
    Ahmed, Tamer S. Said
    Ashraf, Mushtaq
    Hammouda, Danae M.
    MEDICINA-LITHUANIA, 2019, 55 (09):
  • [6] Biomarkers for novel targeted therapies of hepatocellular carcinoma
    Okamoto, Kinya
    Neureiter, Daniel
    Ocker, Matthias
    HISTOLOGY AND HISTOPATHOLOGY, 2009, 24 (04) : 493 - 502
  • [7] Hepatocellular Carcinoma: Review of Targeted and Immune Therapies
    da Motta Girardi D.
    Correa T.S.
    Crosara Teixeira M.
    Dos Santos Fernandes G.
    Journal of Gastrointestinal Cancer, 2018, 49 (3) : 227 - 236
  • [8] Dissection of Signal Transduction Pathways as a Tool for the Development of Targeted Therapies of Hepatocellular Carcinoma
    Calvisi, Diego F.
    Pascale, Rosa M.
    Feo, Francesco
    REVIEWS ON RECENT CLINICAL TRIALS, 2007, 2 (03) : 217 - 236
  • [9] Cuproplasia and cuproptosis in hepatocellular carcinoma: mechanisms, relationship and potential role in tumor microenvironment and treatment
    Ruoyu Zhang
    Yunfei Tan
    Ke Xu
    Ning Huang
    Jian Wang
    Mei Liu
    Liming Wang
    Cancer Cell International, 25 (1)
  • [10] Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma
    Laface, Carmelo
    Ranieri, Girolamo
    Maselli, Felicia Maria
    Ambrogio, Francesca
    Foti, Caterina
    Ammendola, Michele
    Laterza, Marigia
    Cazzato, Gerardo
    Memeo, Riccardo
    Mastrandrea, Giovanni
    Lioce, Marco
    Fedele, Palma
    CANCERS, 2023, 15 (03)